» Articles » PMID: 34178876

Blocking the CCL5-CCR5 Axis Using Maraviroc Promotes M1 Polarization of Macrophages Cocultured with Irradiated Hepatoma Cells

Overview
Date 2021 Jun 28
PMID 34178876
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The C-C chemokine ligand 5 (CCL5)-C-C chemokine receptor (CCR5) axis facilitates tumor progression via multiple mechanisms. Herein, we elucidated the effect of a CCR5 antagonist (maraviroc [MVC]; blocking the CCL5-CCR5 axis) on the phenotype of macrophages cocultured with irradiated hepatoma cells. In addition, we investigated whether modulation of macrophage polarization can alter tumor cell sensitivity to radiation.

Materials And Methods: Quantitative reverse-transcription polymerase chain reaction, Western blotting, and enzyme-linked immunosorbent assays were applied to examine the levels of macrophage-associated markers. The mechanisms of macrophage polarization were explored by Western blotting in an in vitro model of coculture of human hepatoma cells with macrophages. The radiation sensitivity was examined in a clonogenic radiosensitivity assay. Tumor cell apoptosis was detected by Western blotting and flow cytometry. A mouse model of a subcutaneous tumor was also established.

Results: CCL5 skewed THP-1 M0 macrophages toward an M2-like phenotype. In coculture with hepatoma cells, macrophages manifested high levels of interleukin (IL) 10, IL-12, tumor necrosis factor α (TNF-α), transforming growth factor β1 (TGF-β1), arginase 1 (ARG1), and IL-1β. Tumor cell irradiation further upregulated these markers in macrophages. After incubation of macrophages with MVC for 24 h, levels of M1 cytokines significantly increased, whereas those of M2 phenotype factors ARG1, TGF-β1, and IL-10 decreased, accompanied by the activation of signal transducer and activator of transcription 3 (STAT3) and downregulation of suppressor of cytokine signaling 3 (SOCS3). The macrophage phenotype reverted to M2 states after treatment with a STAT3 inhibitor. The shift of macrophages toward the M1 phenotype enhanced the radiosensitivity and apoptosis of hepatoma cells. Mice receiving a combination of X-ray irradiation and MVC experienced a better antitumor effect than those receiving either MVC or irradiation alone did.

Conclusion: M2 polarization of macrophages induced by CCL5-CCR5 signaling can be inhibited using MVC via the STAT3-SOCS3 pathway. The shift of macrophages toward the M1 phenotype promotes the sensitivity of human hepatoma cells to X-ray irradiation.

Citing Articles

The mechanism of cytokine regulation of cancer occurrence and development in the tumor microenvironment and its application in cancer treatment: a narrative review.

Qu R, Zhao Y, Zhang Y Transl Cancer Res. 2024; 13(10):5649-5663.

PMID: 39525000 PMC: 11543031. DOI: 10.21037/tcr-24-679.


Correlation of Immunomodulatory Cytokines with Tumor Volume and Cerebrospinal Fluid in Vestibular Schwannoma Patients.

Becker A, Scholle L, Klause C, Staege M, Strauss C, Otto M Cancers (Basel). 2024; 16(17).

PMID: 39272860 PMC: 11394145. DOI: 10.3390/cancers16173002.


CCL5/CCR5/CYP1A1 pathway prompts liver cancer cells to survive in the combination of targeted and immunological therapies.

Wang Y, Gao B, Jiao T, Zhang W, Shi H, Jiang H Cancer Sci. 2024; 115(11):3552-3569.

PMID: 39183447 PMC: 11531955. DOI: 10.1111/cas.16320.


The Aconitate Decarboxylase 1/Itaconate Pathway Modulates Immune Dysregulation and Associates with Cardiovascular Disease Markers and Disease Activity in Systemic Lupus Erythematosus.

Patino-Martinez E, Nakabo S, Jiang K, Carmona-Rivera C, Tsai W, Claybaugh D J Immunol. 2024; 213(4):419-434.

PMID: 38949522 PMC: 11817569. DOI: 10.4049/jimmunol.2400241.


The aconitate decarboxylase 1/itaconate pathway modulates immune dysregulation and associates with cardiovascular disease markers in SLE.

Patino-Martinez E, Nakabo S, Jiang K, Carmona-Rivera C, Tsai W, Claybaugh D medRxiv. 2024; .

PMID: 38605883 PMC: 11007756. DOI: 10.1101/2024.02.20.24303097.


References
1.
Onuffer J, Horuk R . Chemokines, chemokine receptors and small-molecule antagonists: recent developments. Trends Pharmacol Sci. 2002; 23(10):459-67. DOI: 10.1016/s0165-6147(02)02064-3. View

2.
Zhou L, Wang Z, Gao Y, Wang L, Zeng Z . Stimulation of hepatoma cell invasiveness and metastatic potential by proteins secreted from irradiated nonparenchymal cells. Int J Radiat Oncol Biol Phys. 2012; 84(3):822-8. DOI: 10.1016/j.ijrobp.2012.01.011. View

3.
Pervaiz A, Zepp M, Mahmood S, Ali D, Berger M, Adwan H . CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer. Cell Oncol (Dordr). 2018; 42(1):93-106. DOI: 10.1007/s13402-018-0415-3. View

4.
Gordon P, Okai B, Hoare J, Erwig L, Wilson H . SOCS3 is a modulator of human macrophage phagocytosis. J Leukoc Biol. 2016; 100(4):771-780. DOI: 10.1189/jlb.3A1215-554RR. View

5.
Komohara Y, Jinushi M, Takeya M . Clinical significance of macrophage heterogeneity in human malignant tumors. Cancer Sci. 2013; 105(1):1-8. PMC: 4317877. DOI: 10.1111/cas.12314. View